Trial Outcomes & Findings for Characteristics of Sexual Dysfunction in Patients With Lung Cancer (NCT NCT06018376)
NCT ID: NCT06018376
Last Updated: 2026-02-06
Results Overview
Identify and describe the type, frequency, and severity of sexual disfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population.
COMPLETED
553 participants
From inclusion up to 3 months
2026-02-06
Participant Flow
Participant milestones
| Measure |
Observational Study Group
* Age greater than or equal to 18 years and less than or equal to 70 years.
* Diagnosis of lung cancer stages IB to IV.
* Having received systemic oncological treatment for at least 3 months
* ECOG ≤ 2
|
|---|---|
|
Overall Study
STARTED
|
553
|
|
Overall Study
COMPLETED
|
448
|
|
Overall Study
NOT COMPLETED
|
105
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Observational Study Group
n=448 Participants
* Age greater than or equal to 18 years and less than or equal to 70 years.
* Diagnosis of lung cancer stages IB to IV.
* Having received systemic oncological treatment for at least 3 months
* ECOG ≤ 2
|
|---|---|
|
Sex: Female, Male
Female
|
171 Participants
n=448 Participants
|
|
Sex: Female, Male
Male
|
277 Participants
n=448 Participants
|
|
Region of Enrollment
Spain
|
408 Participants
n=448 Participants
|
|
Region of Enrollment
Colombia
|
18 Participants
n=448 Participants
|
|
Region of Enrollment
Argentina
|
14 Participants
n=448 Participants
|
|
Region of Enrollment
Portugal
|
8 Participants
n=448 Participants
|
|
Smoking status
Smoker
|
256 Participants
n=448 Participants
|
|
Smoking status
Former smoker
|
114 Participants
n=448 Participants
|
|
Smoking status
Never smoker
|
75 Participants
n=448 Participants
|
|
Smoking status
Unknown
|
3 Participants
n=448 Participants
|
|
Age, Continuous
|
60.44 years
STANDARD_DEVIATION 7.29 • n=448 Participants
|
PRIMARY outcome
Timeframe: From inclusion up to 3 monthsIdentify and describe the type, frequency, and severity of sexual disfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population.
Outcome measures
| Measure |
Female Participants
n=171 Participants
Females that met the follwing criteria:
* Age greater than or equal to 18 years and less than or equal to 70 years.
* Diagnosis of lung cancer stages IB to IV.
* Having received systemic oncological treatment for at least 3 months
* ECOG ≤ 2
|
Male Participants
n=277 Participants
Males that met the following criteria:
* Age greater than or equal to 18 years and less than or equal to 70 years.
* Diagnosis of lung cancer stages IB to IV.
* Having received systemic oncological treatment for at least 3 months
* ECOG ≤ 2
|
|---|---|---|
|
Number of Participants With Different Type, Frequency and Severity of Sexual Dysfunction
Severe Disturbances in sexual response phases: Desire
|
71 Participants
|
275 Participants
|
|
Number of Participants With Different Type, Frequency and Severity of Sexual Dysfunction
Severe Disturbances in sexual response phases: Arousal
|
76 Participants
|
51 Participants
|
|
Number of Participants With Different Type, Frequency and Severity of Sexual Dysfunction
Severe Disturbances in sexual response phases_ Orgasm
|
70 Participants
|
71 Participants
|
Adverse Events
Observational Study Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place